| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600710729 |
| P698 | PubMed publication ID | 7120075 |
| P2093 | author name string | H Ehrsson | |
| U Lönroth | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 826-827 | |
| P577 | publication date | 1982-07-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Degradation of melphalan in aqueous solutions--influence of human albumin binding | |
| P478 | volume | 71 |
| Q72592947 | Binding of busulfan to plasma proteins and blood cells |
| Q68631789 | Chromatographic analysis of anticancer drugs |
| Q48133705 | Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. |
| Q92213177 | Determination of melphalan in human plasma by UPLC-UV method |
| Q69021388 | Melphalan concentration dependent plasma protein binding in healthy humans and rats |
| Q69656184 | Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma |
| Q68061875 | Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain |
| Q58030684 | Pharmacokinetics of peptichemio in myeloma patients: release ofm-l-sarcolysin in vivo and in vitro |
| Q69593272 | Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteine |
| Q67927816 | Renal clearance and protein binding of melphalan in patients with cancer |
| Q39814611 | Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents |
| Q77903900 | Synthesis, characterization and antitumor activity of copper(II) complex with nicotinamido-4-bis(2-chloroethyl)aminobenzaldimine |
| Q35991613 | The effect of systemic hyperthermia on melphalan pharmacokinetics in mice |
| Q42371514 | The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma |
Search more.